The current evidence regarding the efficacy of tezepelumab administered for asthma on T2-related comorbidities
{{output}}
Introduction: T2-comorbidities are the most common in severe asthma (SA) patients and have a negative impact on disease outcomes but also an important socio-economic burden. Treating SA and its comorbidities by one medication is ... ...
